Pharmaceutical Development definition
Examples of Pharmaceutical Development in a sentence
Pharmaceutical Development Agreement by and between the Corporation and Ipsen, dated January 2, 2006, as amended by Amendment No. 1, dated January 1, 2007, Amendment No. 2, dated January 1, 2009, and Amendment No. 3, dated June 16, 2010.
We are delighted to be working with Otsuka to fulfill our ambition of developing a range of novel cannabinoid medicines to meet serious unmet medical needs.” ▇▇▇▇ ▇▇▇▇▇▇▇, PhD, President & COO, Otsuka Pharmaceutical Development & Commercialization, Inc., said, “Otsuka is delighted to be entering into this strategic relationship with GW.
During each phase of the development project, POLYPEPTIDE, will make a monthly status report to INTRABIOTICS by fax with originals by mail (Att.: Senior Director of Pharmaceutical Development).
Remit all payments to: Cardinal Health, Pharmaceutical Development, Somerset ▇.▇.
BEAUFOUR ▇▇▇▇▇ INDUSTRIE By: /s/ ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ By: /s/ ▇▇▇▇ ▇▇▇ Name: ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇ Title: CEO Vice-President, Pharmaceutical Development Multi-dose, ready to use Injection for administration using commercially available Pen injector, to deliver a fixed dose between 40-100mcg per day, with 28 days doses in 1.5ml cartridge.
We believe new gene transfer technology will lead the way in therapeutic response, outcomes and survival rates,” said ▇▇▇▇ ▇▇▇▇▇, PhD, Executive Vice President of Research and Pharmaceutical Development of Tocagen.
In addition, within ninety (90) days after the Amendment Effective Date, CDS shall provide to Alimera a Pharmaceutical Development Report, the form and content of which should follow the ICH Guidance documents Q8 Pharmaceutical Development (dated May 19, 2006) and draft Q8(R1) Pharmaceutical Development Revision 1 (dated January 10, 2008).
VARIAGENICS warrants that the NuCleave-TM- Reagents, if properly manufactured in accordance with specifications mutually agreed upon by VARIAGENICS and WATERS as set forth on Schedule 14.2 hereto (the "Specifications") and used in the Pharmaceutical Development Field in accordance with proper procedures on a NuCleave-TM- System, will identify genetic variations as specified in the product literature accompanying the Licensed Product.
WATERS shall have the right to extend such warranty to purchasers of NuCleave-TM- Kits for use on NuCleave-TM- Systems in the Pharmaceutical Development Field.
FibroGen shall report the progress of the items listed above to AstraZeneca’s appointed Pharmaceutical Development contacts on a regular and reasonable basis.